The hypothalamo-pituitary-adrenal axis in multiple sclerosis

Annals of the New York Academy of Sciences

Volumn 992, Issue , 2003, Pages 118-128

  Huitinga, Inge ^a   Erkut, Zeynel A ^a   Van Beurden, Denis ^a   Swaab, Dick F ^a  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

Cortisol; Hypothalamus; Interleukin 6; Multiple sclerosis

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; HYDROCORTISONE; INTERLEUKIN 6;

CEREBROSPINAL FLUID EXAMINATION; CONFERENCE PAPER; CORRELATION ANALYSIS; DISEASE DURATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; INCIDENCE; INFLAMMATION; MULTIPLE SCLEROSIS; RELAPSE; SEPSIS;

EID: 0038806334     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb03143.x     Document Type: Conference Paper

References (30)

1. MARTINELLI, V. 2000. Trauma, stress and multiple sclerosis. Neurol. Sci. 21: S849-852.
2. GOODIN D.S., G. EBERS, K.P. JOHNSON, et al. 1999. The relationship of MS of physical trauma and psychological stress. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 52: 1737-1745.
3. POLMAN, C.H & B.M.J. UITDEHAAG. 2000. Drug treament in multiple sclerosis. Brit. Med. J. 321: 490-494.
4. GOLD, R., F. BUREREIT & K.V. TOYKA. 2001. Mechanism of glucocorticoid hormones: possible implications for therapy of neuroimmunological disorders. J. Neuroimmunol. 117: 1-8.
5. MACPHEE, I.A., F. ANTONI & D.W. MASON. 1989. Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J. Exp. Med. 169: 431-445.
6. MASON, D. 1991. Genetic variation in the stress response: susceptibility to experimental allergic encephalomyelitis and implications for human inflammatory diseases. Immunol. Today 12: 57-61.
7. STERNBERG, E.M. 2001. Neuroendocrine regulation of autoimmune/inflammatory disease. J. Endocrinol. 169: 429-435.
8. STEFFERL, A., M.K. STORCH, C. LININGTON, et al. 2001. Disease progression in chronic relapsing experimental allergic encephalomyelitis is associated with reduced inflammation driven production of corticosterone. Endocrinology 142: 3616-3624.
9. ERKUT, Z.A., M.A. HOFMAN, R. RAVID & D.F. SWAAB. 1995. Increased activity of hypothalamic corticotropin-releasing hormone neurons in multiple sclerosis. J. Neuroimmunol. 62: 27-33.
10. ERKUT, Z.A., E. ENDERT, I. HUITINGA & D. SWAAB. 2002. Cortisol is increased in post mortem cerebrospinal fluid of multiple sclerosis patients: relationship with cytokines. Multiple Sclerosis 8: 229-236.
11. REDER, A.T., R.L. MACKOWIEC & M.T. LOWY. 1994. Adrenal size is increased in multiple sclerosis. Arch. Neurol. 51: 151-154.
12. MICHELSON, D., L. STONE, E. GALLIVEN, et al. 1994. Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function. J. Clin. Endocrinol. Metabol. 79: 848-853.
13. FASSBENDER, K., R. SCHMIDT, R. MÖßNER, et al. 1998. Mood disorders and dysfunction of the hypothalamus-pituitary-adrenal axis in multiple sclerosis. Arch. Neurol. 55: 66-72.
14. GRASSER, A., A. MÖLLER, H. BACKMUND, et al. 1996. Heterogeneity of the hypothalamic-pituitary-adrenal system response to a combined dexamethasone-CRH test in multiple sclerosis. Exp. Clin. Endocrinol. 104: 31-37.
15. THEN BERGH, F., T. KÜMPFEL, C. TRENKWALDER, et al. 1999. Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS. Neurology 53: 772-777.
16. TURNBULL, A.V. & C.L. RIVIER. 1999. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol. Rev. 79: 1-71.
17. BROSNAN, C.F., B. CANELLA, L. BATTISTINI & C.S. RAINE. 1995. Cytokine localization in multiple sclerosis lesions: correlation with adhesion molecule expression and reactive oxygen species. Neurology 45: S16-S21.
18. WHITNALL, M.H. 1993. Regulation of the hypothalamic corticotropin-releasing hormone secretory system. Progr. Neurobiol. 40: 573-629.
19. HUITINGA, I., C.J.A. DE GROOT, P. VAN DER VALK, et al. 2001. Hypothalamic lesions in multiple sclerosis. J. Neuropathol. Exp. Neurol. 60: 1208-1218.
20. DEGROOT, C.J.A., L. BERGERS, W. KAMPHORTS, et al. 2001. Postmortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions. Brain 124: 1635-1645.
21. CHOWDREY, H.S., P.J. LARSEN, M.S. HARBUZ, et al. 1995. Evidence for arginine vasopressin as the primary activator of the HPA axis during adjuvant arthritis. Br. J. Pharmacol. 116: 2417-2424.
22. SAKIC, B., N. LAFLAMME, L.S. CRNIC, et al. 1999. Reduced corticotropin-releasing factor and enhanced vasopressin gene expression in brains of mice with autoimmunity-induced behavioural dysfunction. J. Neuroimmunol. 96: 80-91.
23. GRINEVICH, V., X.M. MA, J.P. HERMAN, et al. 2001. Effect of repeated polysaccharide administration on tissue cytokine expression and hypothalamus pituitary axis activity in rats. J. Neuroendocrinol. 13: 711-723.
24. MEDURI, G.U. & G.P. CHROUSOS. 1998. Duration of glucocorticoid treatment and the outcome in sepsis: is the right drug used in the wrong way? Chest 114: 355-360.
25. HAUSER, S.L., T.H. DOOLITTLE, R. LINCOLN, et al. 1990. Cytokine accumulations in CSF of multiple sclerosis patients. Neurology 40: 1735-1739.
26. SEKIZAWA, T., H. OPENSHAW, K. OHBO, et al. 1998. CSF IL-6 in amyotropic lateral sclerosis: immunological parameter for comparison with inflammatory and noninflammatory central nervous system diseases. J. Neurol. Sci. 154: 194-199.
27. MAIMONE, D., S. GREGORY, B.G. ARNASON & A.T. REDER. 1991. Cytokine levels in cerebrospinal fluid and serum of patients with multiple sclerosis. J. Neuroimmunol. 32: 67-74.
28. MASTORAKIS, G., G. CHROUSOS & J.S. WEBER. 1993. Recombinant IL-6 activates the HPA-axis in humans. J. Clin. Endocrinol. Metabol. 77: 1690-1694.
29. SWAAB, D.F., F.C. RAADSHEER, E. ENDERT, et al. 1994. Increased cortisol levels in aging and Alzheimer's disease in post mortem CSF. J. Neuroendocrinol. 6: 681-687.
30. KONSMAN, J.P., V. TRIDON & R. DANTZER. 2000. Diffusion and action of intracere-broventricularly injected interleukin-1 in the CNS. Neuroscience 101: 957-967.